By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Retrophin, Inc. 

777 Third Avenue
22nd Floor
New York  New York  10017  U.S.A.
Phone: 646-564–3680 Fax:


SEARCH JOBS


Industry
Biotechnology






Company News
Ousted Retrophin (RTRX) CEO Martin Shkreli Launches Turing Pharmaceuticals 2/24/2015 2:40:03 PM
Retrophin (RTRX) To Report Fourth Quarter And Full Year 2014 Financial Results 2/20/2015 11:13:37 AM
Retrophin (RTRX) To Present At The 2015 Leerink Global Healthcare Conference 2/6/2015 12:19:57 PM
Retrophin (RTRX) Announces Voting Results Of Special Meeting Of Stockholders 2/4/2015 9:15:34 AM
Retrophin (RTRX) Announces Voting Results Of Special Meeting Of Stockholders 2/4/2015 8:26:25 AM
Retrophin (RTRX) Snags Cholic Acid Rights From Asklepion Pharmaceuticals in $78 Million Deal 1/12/2015 6:28:09 AM
Ligand Pharmaceuticals Inc. (LGND) Partner Retrophin (RTRX) Receives Orphan Drug Designation For Sparsentan 1/9/2015 11:17:23 AM
Retrophin (RTRX) Provides Corporate Update 1/9/2015 9:25:45 AM
More Trouble for Retrophin (RTRX) Founder 1/8/2015 7:06:18 AM
Retrophin (RTRX) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 1/7/2015 11:57:59 AM
1234567
//-->